Search Results
Research Training
The Postdoctoral Intramural Research Training Award provides full-time, semi-independent research in NHGRI laboratories.
Staff
Dr. Elisabeth F. Heuston is a molecular biology and bioinformatics Staff Scientist with the Center for Research on Genomics and Global Health (CRGGH).
… Johns Hopkins School of Medicine. Under the guidance of mentor Dr. Robert J. Arceci, Dr. Heuston used in vitro …
News
NHGRI has appointed Marcus G. Hodges, Ph.D., as director of its Intramural Training Office (ITO).
The Genomics Landscape
In the June 2024 issue of The Genomics Landscape, NHGRI Director Eric Green recognizes the 2023 recipients of the Bettie J. Graham Leadership Award for Enhancing DEIA in the Genomics Workforce.
… especially women in science, and she has been a mentor for two mid-career female scientists. As an extramural …
Careers and Training
The Health Disparities Unit (HDU) in the Social and Behavioral Research Branch (SBRB) of the National Human Genome Research Institute (NHGRI) is recruiting a postdoctoral fellow interested in the study of the intersection of genomics, social determinants of health and health inequities.
Jobs at NHGRI
NHGRI seeks to identify outstanding tenure-track or tenure-eligible investigators for the newly established Center for Genomics and Data Science Research (CGDSR) within the Division of Intramural Research, located in Bethesda, Maryland.
The Genomics Landscape
In the February 2024 issue of The Genomics Landscape, NHGRI Director Eric Green spotlights the Genome Statute and Legislation Database, which recently received a major revamp to help researchers, policy analysts, and the public more easily find state-level legislation related to genomics.
News Release
Dr. Andy Baxevanis has been named a Fellow of the American Association for the Advancement of Science.
Media Availability
TCGA researchers have found that chromophobe renal cell carcinoma stems partly from gene alterations in the mitochondria, the cell's energy supplier.
Media Availability
The Cancer Genome Atlas identified molecular subtypes to help clinicians determine which tumors are more aggressive and which will respond to treatment.